Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-003291
Filing Date
2025-04-09
Accepted
2025-04-09 06:21:54
Documents
68

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 2151616
2 ex23-1.htm EX-23.1 1084
3 ex23-2.htm EX-23.2 3182
4 ex107.htm EX-FILING FEES 30647
5 ex23-1_001.jpg GRAPHIC 208936
  Complete submission text file 0001641172-25-003291.txt   8158267

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE asbp-20241231.xsd EX-101.SCH 55007
7 XBRL CALCULATION FILE asbp-20241231_cal.xml EX-101.CAL 46730
8 XBRL DEFINITION FILE asbp-20241231_def.xml EX-101.DEF 378790
9 XBRL LABEL FILE asbp-20241231_lab.xml EX-101.LAB 388625
10 XBRL PRESENTATION FILE asbp-20241231_pre.xml EX-101.PRE 379785
70 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 950486
Mailing Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791
Business Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791 561-704-8527
Aspire Biopharma Holdings, Inc. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-286444 | Film No.: 25823767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)